Harvey R Herschman

Title: Innovations of Harvey R. Herschman

Introduction

Harvey R. Herschman is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical imaging through his innovative work. His research focuses on developing selective agents that enhance imaging techniques, particularly in the context of diagnosing and treating various disorders.

Latest Patents

Herschman holds a patent for "Cyclooxygenase-2 selective agents useful as imaging probes and related methods." This invention provides novel cyclooxygenase-2 selective agents that are particularly useful as imaging probes in non-invasive imaging techniques, such as PET and SPECT. The preferred cyclooxygenase-2 selective agents inhibit cyclooxygenase-2 activity with greater potency and specificity than conventional cyclooxygenase-2 inhibitors. Other aspects of the invention include pharmaceutical compositions that incorporate these selective agents, as well as methods for detecting and/or inhibiting cyclooxygenase-2. These methods are particularly useful for diagnosing and treating disorders characterized by elevated cyclooxygenase-2 levels, such as inflammation. Herschman has 1 patent to his name.

Career Highlights

Herschman is affiliated with the University of California, where he continues to contribute to research and innovation in the medical field. His work has implications for improving diagnostic techniques and therapeutic approaches.

Collaborations

Some of his notable coworkers include Nagichettiar Satyamurthy and Michael E. Phelps. Their collaborative efforts have further advanced the research in imaging technologies.

Conclusion

Harvey R. Herschman is a distinguished inventor whose work in cyclooxygenase-2 selective agents has the potential to significantly impact medical imaging and treatment methodologies. His contributions continue to pave the way for advancements in non-invasive diagnostic techniques.